AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 11897014 — intervention group
Group type: COMPARATOR
Intervention: Comparison groups (Groups 2 and 3)
Number of subjects: 28
Study 9834042 — intervention group
Group type: EXPERIMENTAL
Intervention: 10-minute intravenous infusion of 5 microg x kg(‐1) hCRF
Number of subjects: 24
Study 9834042 — intervention group
Group type: EXPERIMENTAL
Intervention: 180-minute intravenous infusion of 5 microg x kg(‐1) hCRF
Number of subjects: 24
Study 9834042 — intervention group
Group type: EXPERIMENTAL
Intervention: Subcutaneous administration of hCRF (300, 600, or 1200 microg)
Number of subjects: 24
Study 9834042 — intervention group
Group type: EXPERIMENTAL
Intervention: Repetitive administration of hCRF
Number of subjects: 24
Study 9834042 — intervention group
Group type: EXPERIMENTAL
Intervention: Relationship between plasma hCRF concentrations and heart rate increase
Number of subjects: 24
Study 9834042 — intervention group
Group type: EXPERIMENTAL
Intervention: Relationship between plasma hCRF concentrations and diastolic blood pressure
Number of subjects: 24
Study 8077989 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose methotrexate (HDMTX) and fluorouracil (FU)
Number of subjects: 101
Study 8077989 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose methotrexate (HDMTX) and fluorouracil (FU) with a 6-hour interval
Number of subjects: 101
Study 2685451 — intervention group
Group type: EXPERIMENTAL
Intervention: Timolol (Chibro‐Timoptol 0.5%)
Number of subjects: 20
Study 49736 — intervention group
Group type: EXPERIMENTAL
Intervention: Propranolol (0-1 mg/kg)
Number of subjects: 6
Study 49736 — intervention group
Group type: EXPERIMENTAL
Intervention: Practolol (1 mg/kg)
Number of subjects: 6
Study 49736 — intervention group
Group type: EXPERIMENTAL
Intervention: Acebutolol (1 mg/kg)
Number of subjects: 6
Study 49736 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6
Study 31660894 — intervention group
Group type: EXPERIMENTAL
Intervention: 3D conformal radiotherapy (VMAT)
Number of subjects: 250
Study 31660894 — intervention group
Group type: COMPARATOR
Intervention: Simple unplanned palliative radiotherapy (SUPR)
Number of subjects: 250
Study 28865924 — intervention group
Group type: EXPERIMENTAL
Intervention: 55.8 Gy (RBE) of fractionated combined proton-photon radiation therapy
Number of subjects: 44
Study 28865924 — intervention group
Group type: COMPARATOR
Intervention: 63.0 Gy (RBE) of fractionated combined proton-photon radiation therapy
Number of subjects: 44
Study 28865924 — intervention group
Group type: EXPERIMENTAL
Intervention: Both doses (55.8 Gy and 63.0 Gy)
Number of subjects: 44
Study 26047682 — intervention group
Group type: EXPERIMENTAL
Intervention: Supervised aerobic and resistance training plus structured exercise counseling (EXE)
Number of subjects: 606
Study 26047682 — intervention group
Group type: COMPARATOR
Intervention: Counseling alone (CON)
Number of subjects: 606
Study 23500281 — intervention group
Group type: EXPERIMENTAL
Intervention: COURAGE
Number of subjects: 5034
Study 23500281 — intervention group
Group type: EXPERIMENTAL
Intervention: BARI 2D
Number of subjects: 5034
Study 23500281 — intervention group
Group type: EXPERIMENTAL
Intervention: FREEDOM
Number of subjects: 5034
Study 21802303 — intervention group
Group type: EXPERIMENTAL
Intervention: Concurrent cognitive task (silent backward counting)
Number of subjects: 23
Study 21802303 — intervention group
Group type: COMPARATOR
Intervention: Single tasking
Number of subjects: 23
Study 21802303 — intervention group
Group type: EXPERIMENTAL
Intervention: Dual tasking
Number of subjects: 23
Study 19374676 — intervention group
Group type: EXPERIMENTAL
Intervention: Nasal cannulae (5 L/minute)
Number of subjects: 106
Study 19374676 — intervention group
Group type: COMPARATOR
Intervention: Oxygen mask (5 L/minute)
Number of subjects: 106
Study 16675091 — intervention group
Group type: EXPERIMENTAL
Intervention: Aceclofenac 100 mg
Number of subjects: 0
Study 16675091 — intervention group
Group type: EXPERIMENTAL
Intervention: Naproxen 500 mg
Number of subjects: 0
Study 16675091 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 14586587 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent running tests to exhaustion
Number of subjects: 6
Study 14586587 — intervention group
Group type: COMPARATOR
Intervention: Continuous running protocol
Number of subjects: 6
Study 10961730 — intervention group
Group type: EXPERIMENTAL
Intervention: mesalamine 1 g two times a day plus Saccharomyces boulardii 1 g daily
Number of subjects: 32
Study 10961730 — intervention group
Group type: COMPARATOR
Intervention: mesalamine 1 g three times a day
Number of subjects: 32
Study 8774552 — intervention group
Group type: EXPERIMENTAL
Intervention: Dynamic training program
Number of subjects: 54
Study 8774552 — intervention group
Group type: COMPARATOR
Intervention: Relaxation training program
Number of subjects: 54
Study 8774552 — intervention group
Group type: COMPARATOR
Intervention: Comparison between groups
Number of subjects: 54
Study 1611155 — intervention group
Group type: EXPERIMENTAL
Intervention: Glyburide 10 mg/d
Number of subjects: 0
Study 1611155 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 6375991 — intervention group
Group type: EXPERIMENTAL
Intervention: Manual suture (Group A)
Number of subjects: 0
Study 6375991 — intervention group
Group type: COMPARATOR
Intervention: Planned stapler suture (Group B)
Number of subjects: 0
Study 6375991 — intervention group
Group type: COMPARATOR
Intervention: Withdrawn cases (Group WD)
Number of subjects: 0
Study 30907198 — intervention group
Group type: EXPERIMENTAL
Intervention: Diet intervention
Number of subjects: 55
Study 30907198 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 55
Study 30907198 — intervention group
Group type: EXPERIMENTAL
Intervention: Weight loss ≥5.0 percent
Number of subjects: 55
Study 30907198 — intervention group
Group type: EXPERIMENTAL
Intervention: Diet group
Number of subjects: 55
Study 30266264 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxytocin
Number of subjects: 144
Study 30266264 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 144
Study 28394002 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 g of omega-3 acids daily for 12 weeks
Number of subjects: 30
Study 28394002 — intervention group
Group type: COMPARATOR
Intervention: Placebo (corn oil 1 g daily for 12 weeks)
Number of subjects: 30
Study 25990625 — intervention group
Group type: EXPERIMENTAL
Intervention: redDAP group
Number of subjects: 206
Study 25990625 — intervention group
Group type: COMPARATOR
Intervention: SG group
Number of subjects: 206
Study 23046851 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral methamphetamine (0, 8 or 16 mg)
Number of subjects: 7
Study 23046851 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 7
Study 23046851 — intervention group
Group type: EXPERIMENTAL
Intervention: Alternative reinforcer ($0.25)
Number of subjects: 7
Study 21944180 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent pneumatic compression (IPC)
Number of subjects: 162
Study 19364887 — intervention group
Group type: EXPERIMENTAL
Intervention: Debridement of type II SLAP lesions
Number of subjects: 48
Study 19364887 — intervention group
Group type: COMPARATOR
Intervention: Repair of type II SLAP lesions
Number of subjects: 48
Study 16740174 — intervention group
Group type: EXPERIMENTAL
Intervention: PV measurement using the constant flow method (PVCF); insufflated volume = 1120 +/- 115 ml, plateau pressure = 46 +/- 11 cmH2O
Number of subjects: 17
Study 16740174 — intervention group
Group type: EXPERIMENTAL
Intervention: PV measurement using a 2 l super syringe (PVSS); insufflated volume = 1824 +/- 381 ml, plateau pressure = 46 +/- 9 cmH2O
Number of subjects: 17
Study 16740174 — intervention group
Group type: COMPARATOR
Intervention: Control period (no PV measurement)
Number of subjects: 17
Study 15356367 — intervention group
Group type: EXPERIMENTAL
Intervention: Antimicrobial wound cleanser (0.057% sodium hypochlorite in isotonic saline solution)
Number of subjects: 18
Study 15356367 — intervention group
Group type: COMPARATOR
Intervention: Normal saline
Number of subjects: 18
Study 15356367 — intervention group
Group type: EXPERIMENTAL
Intervention: Antimicrobial wound cleanser
Number of subjects: 18
Study 10699770 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaled Entonox (50% nitrous oxide, 50% oxygen)
Number of subjects: 102
Study 10699770 — intervention group
Group type: COMPARATOR
Intervention: Intravenous midazolam and meperidine
Number of subjects: 102
Study 9432334 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 mg lansoprazole once in the morning, 200 mg clarithromycin twice daily, and 250 mg metronidazole twice daily for 1 week (LCM1)
Number of subjects: 104
Study 9432334 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 mg lansoprazole once in the morning, 200 mg clarithromycin twice daily, and 500 mg metronidazole twice daily for 1 week (LCM2)
Number of subjects: 104
Study 9432334 — intervention group
Group type: EXPERIMENTAL
Intervention: LCM1
Number of subjects: 104
Study 9432334 — intervention group
Group type: EXPERIMENTAL
Intervention: LCM2
Number of subjects: 104
Study 1402359 — intervention group
Group type: EXPERIMENTAL
Intervention: 15% silver nitrate
Number of subjects: 0
Study 1402359 — intervention group
Group type: EXPERIMENTAL
Intervention: 5% to 25% silver nitrate
Number of subjects: 0
Study 1402359 — intervention group
Group type: COMPARATOR
Intervention: Normal saline (placebo)
Number of subjects: 0
Study 3841333 — intervention group
Group type: EXPERIMENTAL
Intervention: 3 or 6 cycles of MOPP followed by Mantle field with or without mediastinal irradiation and/or inverted Y or lumboaortic field
Number of subjects: 334
Study 3841333 — intervention group
Group type: COMPARATOR
Intervention: 6 cycles of MOPP
Number of subjects: 334
Study 3841333 — intervention group
Group type: EXPERIMENTAL
Intervention: 3 cycles of MOPP followed by irradiation
Number of subjects: 334
Study 3841333 — intervention group
Group type: EXPERIMENTAL
Intervention: 3 cycles of MOPP and radiotherapy
Number of subjects: 334
Study 3593624 — intervention group
Group type: EXPERIMENTAL
Intervention: Y-8894 50 mg
Number of subjects: 18
Study 3593624 — intervention group
Group type: COMPARATOR
Intervention: Nortriptyline 50 mg
Number of subjects: 18
Study 31918685 — intervention group
Group type: EXPERIMENTAL
Intervention: Ranibizumab treatment guided by best-corrected visual acuity (BCVA) loss (Group I)
Number of subjects: 671
Study 31918685 — intervention group
Group type: EXPERIMENTAL
Intervention: Ranibizumab treatment guided by BCVA loss and/or signs of disease activity on optical coherence tomography (OCT; Group II)
Number of subjects: 671
Study 30025734 — intervention group
Group type: EXPERIMENTAL
Intervention: USCDT with 4 mg tPA/lung for 2 hours
Number of subjects: 101
Study 30025734 — intervention group
Group type: EXPERIMENTAL
Intervention: USCDT with 4 mg tPA/lung for 4 hours
Number of subjects: 101
Study 30025734 — intervention group
Group type: EXPERIMENTAL
Intervention: USCDT with 6 mg tPA/lung for 6 hours
Number of subjects: 101
Study 30025734 — intervention group
Group type: EXPERIMENTAL
Intervention: USCDT with 12 mg tPA/lung for 6 hours
Number of subjects: 101
Study 30025734 — intervention group
Group type: EXPERIMENTAL
Intervention: All USCDT groups
Number of subjects: 101
Study 30025734 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 101
Study 28279200 — intervention group
Group type: EXPERIMENTAL
Intervention: Book-sharing intervention group
Number of subjects: 0
Study 28279200 — intervention group
Group type: COMPARATOR
Intervention: Wait-list control group
Number of subjects: 0
Study 25786048 — intervention group
Group type: EXPERIMENTAL
Intervention: Duloxetine 60 mg/day
Number of subjects: 65
Study 25786048 — intervention group
Group type: EXPERIMENTAL
Intervention: Acetyl L-carnitine 1500 mg/day (500 mg t.i.d.)
Number of subjects: 65
Study 24064773 — intervention group
Group type: EXPERIMENTAL
Intervention: Calorie-limited diet, physical exercise, and cognitive behavioral training during working hours 1 hour per week
Number of subjects: 144
Study 24064773 — intervention group
Group type: COMPARATOR
Intervention: Presentations about healthy lifestyle
Number of subjects: 144
Study 20332060 — intervention group
Group type: EXPERIMENTAL
Intervention: Milnacipran
Number of subjects: 1260
Study 18203046 — intervention group
Group type: EXPERIMENTAL
Intervention: 5-HT stimulation
Number of subjects: 25
Study 18203046 — intervention group
Group type: EXPERIMENTAL
Intervention: 5-HT stimulation during treatment
Number of subjects: 25
Study 18203046 — intervention group
Group type: EXPERIMENTAL
Intervention: Antidepressant treatment in patients with depression
Number of subjects: 25
Study 16365055 — intervention group
Group type: EXPERIMENTAL
Intervention: Betaine 3 g
Number of subjects: 10
Study 16365055 — intervention group
Group type: EXPERIMENTAL
Intervention: Betaine 6 g
Number of subjects: 10
Study 16365055 — intervention group
Group type: COMPARATOR
Intervention: Betaine 1 g
Number of subjects: 10
Study 16365055 — intervention group
Group type: EXPERIMENTAL
Intervention: Betaine (all doses)
Number of subjects: 10
Study 14564940 — intervention group
Group type: EXPERIMENTAL
Intervention: Multi‐micronutrient supplement (S)
Number of subjects: 0
Study 14564940 — intervention group
Group type: EXPERIMENTAL
Intervention: Multi‐micronutrient supplement plus test meal (MS)
Number of subjects: 0
Study 14564940 — intervention group
Group type: COMPARATOR
Intervention: Test meal (M)
Number of subjects: 0
Study 11186161 — intervention group
Group type: EXPERIMENTAL
Intervention: Cystinosis group
Number of subjects: 141
Study 11186161 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 141
Study 8863312 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgical intervention (root-end resection and root-end filling)
Number of subjects: 38
Study 8863312 — intervention group
Group type: COMPARATOR
Intervention: Conventional retreatment
Number of subjects: 38
Study 1735488 — intervention group
Group type: COMPARATOR
Intervention: Single periovulatory intrauterine insemination (IUI)
Number of subjects: 31
Study 1735488 — intervention group
Group type: EXPERIMENTAL
Intervention: Double intrauterine insemination (IUI) - one before ovulation and one after ovulation
Number of subjects: 31
Study 6588726 — intervention group
Group type: EXPERIMENTAL
Intervention: Professional tooth-cleaning plus fluoride mouth-rinsing every 3rd week
Number of subjects: 0
Study 6588726 — intervention group
Group type: COMPARATOR
Intervention: Fluoride varnish treatment every 6 months
Number of subjects: 0
Study 6588726 — intervention group
Group type: EXPERIMENTAL
Intervention: Individualized prevention measures based on estimated needs
Number of subjects: 0
Study 6588726 — intervention group
Group type: EXPERIMENTAL
Intervention: Professional tooth-cleaning plus fluoride mouth-rinsing
Number of subjects: 0
Study 29926431 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapeutic education programme 'PETAL' for laryngectomised patients and their close relations; details on dosage and duration not specified.
Number of subjects: 0
Study 29926431 — intervention group
Group type: EXPERIMENTAL
Intervention: Pilot phase of the programme; details on dosage and duration not specified.
Number of subjects: 0
Study 29926431 — intervention group
Group type: EXPERIMENTAL
Intervention: Prospective intervention 'replication' phase; details on dosage and duration not specified.
Number of subjects: 0
Study 29926431 — intervention group
Group type: EXPERIMENTAL
Intervention: Cluster-randomised multicentric comparative intervention phase; details on dosage and duration not specified.
Number of subjects: 0
Study 29144178 — intervention group
Group type: EXPERIMENTAL
Intervention: Evening-dosing of DCF regimen
Number of subjects: 0
Study 29144178 — intervention group
Group type: COMPARATOR
Intervention: Morning-dosing of DCF regimen
Number of subjects: 0
Study 26853293 — intervention group
Group type: EXPERIMENTAL
Intervention: Subepidermal triamcinolone injections (4mg per cc, 5mm intervals until complete blanching)
Number of subjects: 42
Study 26853293 — intervention group
Group type: COMPARATOR
Intervention: Kligman's formula (hydroquinone 5%, tretinoin 0.1%, dexamethasone 0.1%)
Number of subjects: 42
Study 24875781 — intervention group
Group type: EXPERIMENTAL
Intervention: Dabigatran
Number of subjects: 2579
Study 24875781 — intervention group
Group type: EXPERIMENTAL
Intervention: Rivaroxaban
Number of subjects: 2579
Study 22312173 — intervention group
Group type: EXPERIMENTAL
Intervention: School-wide Positive Behavioral Interventions and Supports (SWPBIS)
Number of subjects: 12344
Study 22312173 — intervention group
Group type: COMPARATOR
Intervention: Control group (schools without SWPBIS)
Number of subjects: 12344
Study 20207720 — intervention group
Group type: EXPERIMENTAL
Intervention: 100% of the RDA for SAA, 15 mg/kg APAP given on day 3
Number of subjects: 0
Study 20207720 — intervention group
Group type: COMPARATOR
Intervention: 0% of the RDA for SAA, 15 mg/kg APAP given on day 3
Number of subjects: 0
Study 20207720 — intervention group
Group type: EXPERIMENTAL
Intervention: 100% of the RDA for SAA, placebo given on day 3
Number of subjects: 0
Study 20207720 — intervention group
Group type: COMPARATOR
Intervention: 0% of the RDA for SAA, placebo given on day 3
Number of subjects: 0
Study 18687168 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol
Number of subjects: 60
Study 18687168 — intervention group
Group type: EXPERIMENTAL
Intervention: Midazolam
Number of subjects: 60
Study 18687168 — intervention group
Group type: EXPERIMENTAL
Intervention: Midazolam and Propofol combination
Number of subjects: 60
Study 16019883 — intervention group
Group type: EXPERIMENTAL
Intervention: Desktop text telephones with direct connection
Number of subjects: 28
Study 16019883 — intervention group
Group type: COMPARATOR
Intervention: Desktop text telephones with acoustic connection
Number of subjects: 28
Study 11571734 — intervention group
Group type: EXPERIMENTAL
Intervention: Groshong catheter (experimental group)
Number of subjects: 304
Study 11571734 — intervention group
Group type: COMPARATOR
Intervention: Open-ended catheter (control group)
Number of subjects: 304
Study 9590466 — intervention group
Group type: COMPARATOR
Intervention: KA 672-HCl 40 mg single dose
Number of subjects: 100
Study 9590466 — intervention group
Group type: COMPARATOR
Intervention: KA 672-HCl 60 mg single dose
Number of subjects: 100
Study 9590466 — intervention group
Group type: COMPARATOR
Intervention: KA 672-HCl 10 mg repeated doses for 14 days
Number of subjects: 100
Study 9590466 — intervention group
Group type: COMPARATOR
Intervention: KA 672-HCl 20 mg repeated doses for 14 days
Number of subjects: 100
Study 9590466 — intervention group
Group type: COMPARATOR
Intervention: KA 672-HCl repeated doses
Number of subjects: 100
Study 9590466 — intervention group
Group type: COMPARATOR
Intervention: KA 672-HCl single dose
Number of subjects: 100
Study 9590466 — intervention group
Group type: COMPARATOR
Intervention: KA 672-HCl 20 mg single dose
Number of subjects: 100
Study 9590466 — intervention group
Group type: COMPARATOR
Intervention: KA 672-HCl 20 mg repeated doses
Number of subjects: 100
Study 8072816 — intervention group
Group type: EXPERIMENTAL
Intervention: DTP-IPV-PRPT
Number of subjects: 161
Study 8072816 — intervention group
Group type: COMPARATOR
Intervention: DTP-IPV-placebo
Number of subjects: 161
Study 3384164 — intervention group
Group type: EXPERIMENTAL
Intervention: Amoxycillin/clavulanic acid (2.2 g preoperative dose)
Number of subjects: 251
Study 3384164 — intervention group
Group type: COMPARATOR
Intervention: Cefuroxim (1.5 g) combined with Metronidazole (0.5 g)
Number of subjects: 251
Study 31010007 — intervention group
Group type: EXPERIMENTAL
Intervention: CIPA nutrition screening and treatment
Number of subjects: 412
Study 31010007 — intervention group
Group type: COMPARATOR
Intervention: Standard clinical care
Number of subjects: 412
Study 28706176 — intervention group
Group type: EXPERIMENTAL
Intervention: Memory and visual-motor integration program (12 sessions over 6 weeks)
Number of subjects: 62
Study 28706176 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 62
Study 26488155 — intervention group
Group type: EXPERIMENTAL
Intervention: SYSTANE BALANCE Lubricant Eye Drops (n=76)
Number of subjects: 106
Study 26488155 — intervention group
Group type: COMPARATOR
Intervention: Habitual nonlipid contact lens rewetting eye drop (n=30)
Number of subjects: 106
Study 24120754 — intervention group
Group type: EXPERIMENTAL
Intervention: Progressive Resistance Training (PRT) programme, trained twice a week for 10 weeks at a community gymnasium with a physiotherapy student mentor using pin-loaded weight machines
Number of subjects: 68
Study 24120754 — intervention group
Group type: EXPERIMENTAL
Intervention: Progressive Resistance Training (PRT) programme
Number of subjects: 68
Study 24120754 — intervention group
Group type: COMPARATOR
Intervention: Social group (control), completed a 10-week programme of social activities once a week for 90 min with a student mentor
Number of subjects: 68
Study 21046372 — intervention group
Group type: EXPERIMENTAL
Intervention: Phaffia rhodozyma
Number of subjects: 0
Study 21046372 — intervention group
Group type: COMPARATOR
Intervention: Haematococcus pluvialis
Number of subjects: 0
Study 21046372 — intervention group
Group type: COMPARATOR
Intervention: Chemical synthesis
Number of subjects: 0
Study 20183413 — intervention group
Group type: EXPERIMENTAL
Intervention: Condensed Seeking Safety intervention (six sessions)
Number of subjects: 104
Study 20183413 — intervention group
Group type: COMPARATOR
Intervention: Standard chemical dependence intervention
Number of subjects: 104
Study 20183413 — intervention group
Group type: EXPERIMENTAL
Intervention: Condensed Seeking Safety intervention
Number of subjects: 104
Study 17708865 — intervention group
Group type: EXPERIMENTAL
Intervention: Low lactose milk
Number of subjects: 68
Study 17708865 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactase-fermented milk
Number of subjects: 68
Study 17708865 — intervention group
Group type: EXPERIMENTAL
Intervention: Coinfected milk
Number of subjects: 68
Study 17708865 — intervention group
Group type: EXPERIMENTAL
Intervention: Yogurt
Number of subjects: 68
Study 17708865 — intervention group
Group type: EXPERIMENTAL
Intervention: Milk with meal
Number of subjects: 68
Study 15510531 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurse-coaching intervention (5 individualized sessions and 2 follow-up phone calls over 6 months)
Number of subjects: 53
Study 15510531 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurse-coaching intervention
Number of subjects: 53
Study 15510531 — intervention group
Group type: COMPARATOR
Intervention: Standard care control
Number of subjects: 53
Study 11900312 — intervention group
Group type: EXPERIMENTAL
Intervention: Active PEMF treatment
Number of subjects: 75
Study 11900312 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 75
Study 10089797 — intervention group
Group type: EXPERIMENTAL
Intervention: Provox voice prosthesis
Number of subjects: 15
Study 10089797 — intervention group
Group type: COMPARATOR
Intervention: LR Groningen prosthesis
Number of subjects: 15